ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,187.70
      0.13%
      US Tech 100
      17,567.20
      -0.26%
      Dow Jones
      38,884.26
      0.00%
      Brent Oil
      81.965
      -1.09%
      Bitcoin
      62,261.07
      -0.12%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Stealth BioTherapeutics Corporation (MITO)

      7. Stealth BioTherapeutics Corporation (MITO) News

      MITO

      Stealth BioTherapeutics (MITO)

      Stealth BioTherapeutics Corporation
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MITO
      DateTimeSourceHeadlineSymbolCompany
      12:51PMiHub NewswireFeaturedCannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa
      11/28/20226:41PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:MITOStealth BioTherapeutics Corporation
      11/16/20224:23PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MITOStealth BioTherapeutics Corporation
      11/16/20224:22PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MITOStealth BioTherapeutics Corporation
      11/16/20224:20PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MITOStealth BioTherapeutics Corporation
      11/16/20224:19PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MITOStealth BioTherapeutics Corporation
      11/16/20224:16PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:MITOStealth BioTherapeutics Corporation
      11/16/20224:14PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:MITOStealth BioTherapeutics Corporation
      11/16/20224:10PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MITOStealth BioTherapeutics Corporation
      11/16/20224:08PMEdgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:MITOStealth BioTherapeutics Corporation
      11/16/20224:01PMPR Newswire (US)Stealth BioTherapeutics Corp Announces Completion of MergerNASDAQ:MITOStealth BioTherapeutics Corporation
      11/01/20227:30AMPR Newswire (US)Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)NASDAQ:MITOStealth BioTherapeutics Corporation
      10/07/20224:01PMPR Newswire (US)Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of ShareholdersNASDAQ:MITOStealth BioTherapeutics Corporation
      09/30/20225:01PMTipRanksStealth Biotherapeutics announces resignation of CFO Robert WeiskopfNASDAQ:MITOStealth BioTherapeutics Corporation
      09/30/20225:00PMPR Newswire (US)Stealth BioTherapeutics Announces Departure of Chief Financial OfficerNASDAQ:MITOStealth BioTherapeutics Corporation
      09/23/20225:21PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MITOStealth BioTherapeutics Corporation
      09/15/20224:45PMPR Newswire (US)Stealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease EventsNASDAQ:MITOStealth BioTherapeutics Corporation
      08/19/20224:16PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MITOStealth BioTherapeutics Corporation
      08/19/20229:50AMEdgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)NASDAQ:MITOStealth BioTherapeutics Corporation
      08/01/20224:46PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MITOStealth BioTherapeutics Corporation
      08/01/20229:48AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MITOStealth BioTherapeutics Corporation
      08/01/20228:30AMPR Newswire (US)Stealth BioTherapeutics Corp Enters Definitive Agreement for Going Private TransactionNASDAQ:MITOStealth BioTherapeutics Corporation
      07/11/20225:21PMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MITOStealth BioTherapeutics Corporation
      07/11/20225:15PMPR Newswire (US)STEALTH BIOTHERAPEUTICS ANNOUNCES RECEIPT OF NON-COMPLIANCE NOTICE FROM NASDAQNASDAQ:MITOStealth BioTherapeutics Corporation
      06/27/20224:50PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MITOStealth BioTherapeutics Corporation
      06/27/202210:25AMAllPennyStocks.comPremarket Indicating Higher Open For This BiotechNASDAQ:MITOStealth BioTherapeutics Corporation
      06/27/20228:02AMEdgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:MITOStealth BioTherapeutics Corporation
      06/27/20227:30AMPR Newswire (US)Stealth BioTherapeutics Corp Announces Receipt of Preliminary Non-Binding ProposalNASDAQ:MITOStealth BioTherapeutics Corporation
      06/16/20226:15AMTipRanksH.C. Wainwright Thinks Stealth Biotherapeutics’ Stock is Going to RecoverNASDAQ:MITOStealth BioTherapeutics Corporation
      06/16/20226:05AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MITOStealth BioTherapeutics Corporation
       Showing the most relevant articles for your search:NASDAQ:MITO